VDPharmacy
ActiveSummary
VDPharmacy has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €170,901 and a net result of -€3,366. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 26% of 2,801 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Articles of association
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Artikel 11. Bevoegdheden van het bestuursorgaan Bestuursbevoegdheid: De enige bestuurder of elke bestuurder afzonderlijk zo er meerdere…”
- Board ruleHow the board is made up, meets and takes decisions.
- “1, één of meer bestuurders” (deed in Dutch)“Vaste of evenredige vergoeding, al dan niet ten kosteloze titel” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- In June